Osteosarcoma Cell-Derived Exosomal ELFN1-AS1 Mediates Macrophage M2 Polarization Sponging MiR-138-5p and MiR-1291 to Promote the Tumorgenesis of Osteosarcoma
Overview
Affiliations
Background: Exosomes play an important role in cell-cell communication by transferring genetic materials such as long non-coding RNAs (lncRNAs) between cancer cells and tumor-associated macrophages (TAMs) in the tumor microenvironment (TME). Recent studies revealed that lncRNA ELFN1-AS1 could function as an oncogene in many human cancers. However, the role of extracellular lncRNA ELFN1-AS1 in cell-to-cell communication of osteosarcoma (OS) has not been fully investigated.
Methods: Functional studies, including CCK-8, EdU staining and transwell assay were performed to investigate the role of ELFN1-AS1 in the progression of OS. 143B xenograft mouse model was established to assess the role of ELFN1-AS1 . In addition, transmission electron microscopy (TEM) and real-time quantitative PCR (RT-qPCR) assay were used to verify the existence of exosomal ELFN1-AS1.
Results: The level of ELFN1-AS1 was markedly upregulated in patients with advanced OS and in OS cells. In addition, overexpression of ELFN1-AS1 significantly promoted the proliferation, migration and invasion of OS cells, while knockdown of ELFN1-AS1 exhibited the opposite effects. Meanwhile, ELFN1-AS1 could be transferred from OS cells to macrophages exosomes. Exosomal ELFN1-AS1 from 143B cells was able to promote macrophage M2 polarization, and M2 macrophage in return facilitated OS progression. Mechanistically, overexpression of ELFN1-AS1 upregulated CREB1 level sponging miR-138-5p and miR-1291 in macrophage .
Conclusion: OS cell-derived exosomal ELFN1-AS1 was able to induce macrophage M2 polarization sponging miR-138-5p and miR-1291, and M2 macrophage notably facilitated the progression of OS. These data suggested that ELFN1-AS1 might serve as a potential therapeutic target for osteosarcoma.
The role of tumor-derived exosomal LncRNA in tumor metastasis.
Yu Z, Fu J, Mantareva V, Blazevic I, Wu Y, Wen D Cancer Gene Ther. 2025; .
PMID: 40011710 DOI: 10.1038/s41417-024-00852-x.
Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z Cancer Cell Int. 2025; 25(1):29.
PMID: 39885569 PMC: 11783933. DOI: 10.1186/s12935-025-03659-4.
Ye Z, Yi J, Jiang X, Shi W, Xu H, Cao H J Exp Clin Cancer Res. 2025; 44(1):2.
PMID: 39748408 PMC: 11694445. DOI: 10.1186/s13046-024-03269-4.
Liu X, Ye J, Guo W, Wang J Front Cell Dev Biol. 2024; 12:1473044.
PMID: 39605980 PMC: 11599209. DOI: 10.3389/fcell.2024.1473044.
Role of non-coding RNA in exosomes for the diagnosis and treatment of osteosarcoma.
Liu X, Wang Y, Wang C, Wang X, Tang G, Xiong Z Front Oncol. 2024; 14:1469833.
PMID: 39512768 PMC: 11540661. DOI: 10.3389/fonc.2024.1469833.